Form 4: NeueHealth CFO Jay Matushak Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
NeueHealth's CFO, Jay Matushak, sold 1,083 shares of common stock on March 18, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On March 18, 2024, Jay Matushak, the Chief Financial Officer of NeueHealth, Inc., sold 1,083 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $7.27, with individual transaction prices ranging from $7.16 to $7.39 per share.
- Following the transaction, Matushak directly owns 8,643 shares of NeueHealth common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to a stock sale for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/18/2024 | Date of stock sale transaction |
| 03/20/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.